Value of Early Surgery in Small Intestinal Crohn's Disease / 胃肠病学

ABSTRACT

Crohn's disease (CD) is a gastrointestinal tract chronic inflammatory disease with an increasing incidence worldwide. Treatment of CD is focused on symptom control and healing the intestinal mucosa in order to improve the quality of life and prevent complications. The early use of anti-TNF agents such as infliximab in CD patients with high risk factors has become the main treatment of CD clinically. However, infliximab has its limitations, early surgery might benefit the patient more. This article reviewed the therapeutic value of early surgery in small intestinal CD.